Preclinical peptide research, explained.
We read the animal-model peptide literature so a general reader can understand what it actually says — and, just as carefully, what it does not.
Model Organism is an independent, non-commercial publication about preclinical peptide research — the rat studies, mouse models, and cell-culture experiments that make up nearly all of what is actually known about compounds like BPC-157, thymosin beta-4, and GHK-Cu. Most accessible writing on these peptides comes from people with something to sell. We started this publication because we thought a general reader deserved a version written by people with nothing to sell, in which the phrase "in Sprague-Dawley rats" appears as often as the data require.
Our editorial standards are simple and public: we name the species and model in every summary, we state the evidence gaps as plainly as the findings, we do not cite papers we have not read, and we correct our mistakes in the open. We accept no advertising, sell no products, and take no position on any use of any compound. Where a peptide has essentially no rigorous human evidence — which is most of them — we say so in the first paragraph, not the last.
Four questions worth asking of any preclinical paper — the same four we ask before we summarize one.
Many animal studies run six to ten animals per group. At that scale, chance alone produces striking results with some regularity. Small n is not a flaw by itself — but it is a reason to wait for more.
Was the person scoring the tissue slides aware of which group each animal was in? Unblinded outcome assessment is one of the best-documented sources of inflated effects in animal research.
Has any group outside the original laboratory reproduced the finding? A result replicated across independent labs, species, and models carries a different weight than one repeated within a single research network.
A paper that measures many outcomes and reports the ones that moved is describing noise as often as signal. Look for pre-specified primary endpoints — and be wary when every study picks a different one.
